More than 2,000 participants joined us at the SummeRun & Walk for Ovarian Cancer on Sunday, July 14th — helping raise awareness and funds for critical ovarian cancer research and education. We are so grateful for the support of the community at this inspirational event every year, and this one did not disappoint! Sachia Powell […]
Read MoreAs the annual Swedish SummeRun & Walk for Ovarian Cancer approaches, we wanted to share some fun and creative ways participants have been raising money for their SummeRun teams. Host a Silent Auction Kevin Westrick and his daughter, Whitney, started Rockin’ for Rosie in 2014. The event is in honor of Kevin’s mother, Rosemarie “Rosie”, who passed away […]
Read MoreSeattle, WA: The Rivkin Center, a Seattle-based 501(c)(3), announced that they have awarded $1.455 million in ovarian cancer research grants to sixteen scientists across the globe. The amount funded was nearly a 20% increase over last year. The Rivkin Center’s unique approach to funding provides researchers leverage to access larger pots of federal funds for […]
Read MoreThe Rivkin Center’s Education Program The Rivkin Center’s education program provides free health education workshops. Instructors educate women about their breast and ovarian health and cancer risks. Say hello to Kristin Anderson, one of our instructors. ABOUT KRISTIN Where are you from? I grew up in Prior Lake, Minnesota (30 minutes south of the Twin […]
Read MoreThe Rivkin Center’s education program provides free health education workshops. Rivkin EDU campus ambassadors are the feet-on-the-ground Rivkin Center representatives at universities across the west coast, helping set up workshops, identify opportunities to reach more students, and so much more. Say hello to Elena Santana, a Rivkin EDU campus ambassador at the University of Arizona. […]
Read MoreAfter more than twenty years, we’re excited to unveil a new look and logo for the Rivkin Center. We believe the new brand reflects our aspiration to make a bigger impact for more women now and in the future. Our new brand more clearly represents all aspects of our programs: research, education, and high-risk […]
Read MoreThe Federal Drug Administration (FDA) made an exciting announcement this week with the first approval for PARP inhibitors to be used for patients following their initial diagnosis and treatment to reduce the risk of recurrence. The FDA approved the use of the PARP inhibitor olaparib (Lynparza®) for frontline maintenance therapy for advanced epithelial ovarian, fallopian […]
Read MoreThe world changed for Bobbie Hinton when her mother, Colleen Kirwin, lost her eight-year battle with ovarian cancer in 2011. Four years later, Bobbie herself was diagnosed with breast cancer. Bobbie and her husband, Dave, are inspired by the work of the Rivkin Center and its fight against two devastating diseases for women: breast cancer […]
Read MoreThe Rivkin Center’s education program provides free health education workshops across the west coast. Rivkin EDU survivors share their cancer journey with party attendees and help educate women on ovarian and breast health, while instructors educate women about their breast and ovarian health and cancer risks. Say hello to Helen Chen, Rivkin EDU instructor and […]
Read More